- Home
- SCPH vs TSI Comparison
SCPH vs TSI Comparison
Compare SCPH & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- TSI
- Stock Information
- Founded
- SCPH 2013
- TSI 1987
- Country
- SCPH United States
- TSI United States
- Employees
- SCPH N/A
- TSI N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- TSI Investment Managers
- Sector
- SCPH Health Care
- TSI Finance
- Exchange
- SCPH Nasdaq
- TSI Nasdaq
- Market Cap
- SCPH 274.7M
- TSI 237.0M
- IPO Year
- SCPH 2017
- TSI N/A
- Fundamental
- Price
- SCPH $3.43
- TSI $4.96
- Analyst Decision
- SCPH Strong Buy
- TSI
- Analyst Count
- SCPH 2
- TSI 0
- Target Price
- SCPH $15.00
- TSI N/A
- AVG Volume (30 Days)
- SCPH 494.3K
- TSI 106.8K
- Earning Date
- SCPH 11-13-2024
- TSI 01-01-0001
- Dividend Yield
- SCPH N/A
- TSI 7.46%
- EPS Growth
- SCPH N/A
- TSI N/A
- EPS
- SCPH N/A
- TSI N/A
- Revenue
- SCPH $30,278,000.00
- TSI N/A
- Revenue This Year
- SCPH $195.62
- TSI N/A
- Revenue Next Year
- SCPH $145.07
- TSI N/A
- P/E Ratio
- SCPH N/A
- TSI N/A
- Revenue Growth
- SCPH 303.87
- TSI N/A
- 52 Week Low
- SCPH $3.08
- TSI $4.48
- 52 Week High
- SCPH $6.71
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- SCPH 32.05
- TSI 43.39
- Support Level
- SCPH $3.25
- TSI $4.91
- Resistance Level
- SCPH $3.60
- TSI $5.11
- Average True Range (ATR)
- SCPH 0.23
- TSI 0.06
- MACD
- SCPH -0.07
- TSI -0.01
- Stochastic Oscillator
- SCPH 18.95
- TSI 23.81
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment, and others.